News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Veradigm

Advertisement

Articles by Veradigm

Pharmacovigilance in the 21st Century: How to Improve Real-World Safety Reporting through Point-of-Care Technology

Pharmacovigilance in the 21st Century: How to Improve Real-World Safety Reporting through Point-of-Care Technology

ByVeradigm
November 21st 2022

Webinar Date/Time: Thu, Dec 8, 2022 2:00 PM EST

Registry vs. EHR Data for Real-World Evidence Generation: Heart Failure as a Case Study

Registry vs. EHR Data for Real-World Evidence Generation: Heart Failure as a Case Study

ByVeradigm
August 30th 2022

Tue, Aug 30, 2022 11:00 AM EDT Demand for real-world evidence (RWE) is rising. But which data sources can meet the need for actionable RWE? EHR vs. registry data—which is better?

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on PharmExec

    1

    Vinay Prasad Out at CBER for Second Time in Under a Year

    2

    Key Factors Contributing to Uncertainty in Moderna's mRNA Vaccine Review

    3

    Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial

    4

    Novo Nordisk Signs Deal with Hims & Hers

    5

    Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals

    • About
    • Advertise
    • Contact Us
    • Editorial Board
    • Editorial Submission Guidelines
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us